Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Molecular Imaging and Biology
|
December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in Mice
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 16, 2022
Validation, kinetic modeling, and test-retest reproducibility of [<sup>18</sup>F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice
Daniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, et al.
Neuroimage
|
March 5, 2019
PET imaging of freely moving interacting rats
Alan Miranda, Min Su Kang, Stephan Blinder, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
May 26, 2024
Risk assessment due to natural radioactivity of stone dust and crushed stone Commercialized in construction stores in the state of Rio de Janeiro
Leandro Barbosa Silva, Lucas Faria da Silva, Carlos Omar Pastrana Orejuela, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2024
Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
Franziska Zajicek, Jeroen Verhaeghe, Stef De Lombaerde, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Bioconjugate Chemistry
|
August 12, 2025
Synthesis and Preclinical Evaluation of Druglike <sup>18</sup>F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention
Karuna Adhikari, Sergei Grintsevich, Anke de Groot, et al.
Molecular Neurobiology
|
January 9, 2020
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 18, 2025
Preclinical evaluation of [<sup>11</sup>C]CHDI-009R for quantification of mutant huntingtin aggregates
Franziska Zajicek, Liesbeth Everix, Annemie Van Eetveldt, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Molecular Imaging and Biology
|
December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in Mice
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 16, 2022
Validation, kinetic modeling, and test-retest reproducibility of [<sup>18</sup>F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice
Daniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, et al.
Neuroimage
|
March 5, 2019
PET imaging of freely moving interacting rats
Alan Miranda, Min Su Kang, Stephan Blinder, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
May 26, 2024
Risk assessment due to natural radioactivity of stone dust and crushed stone Commercialized in construction stores in the state of Rio de Janeiro
Leandro Barbosa Silva, Lucas Faria da Silva, Carlos Omar Pastrana Orejuela, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2024
Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
Franziska Zajicek, Jeroen Verhaeghe, Stef De Lombaerde, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Bioconjugate Chemistry
|
August 12, 2025
Synthesis and Preclinical Evaluation of Druglike <sup>18</sup>F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention
Karuna Adhikari, Sergei Grintsevich, Anke de Groot, et al.
Molecular Neurobiology
|
January 9, 2020
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 18, 2025
Preclinical evaluation of [<sup>11</sup>C]CHDI-009R for quantification of mutant huntingtin aggregates
Franziska Zajicek, Liesbeth Everix, Annemie Van Eetveldt, et al.
Page
of 5